221 related articles for article (PubMed ID: 2345775)
1. Differential effect of cigarette smoking on antipyrine oxidation versus acetaminophen conjugation.
Scavone JM; Greenblatt DJ; LeDuc BW; Blyden GT; Luna BG; Harmatz JS
Pharmacology; 1990; 40(2):77-84. PubMed ID: 2345775
[TBL] [Abstract][Full Text] [Related]
2. Differential effects of isoniazid and oral contraceptive steroids on antipyrine oxidation and acetaminophen conjugation.
Ochs HR; Greenblatt DJ; Verburg-Ochs B; Abernethy DR; Knüchel M
Pharmacology; 1984; 28(4):188-95. PubMed ID: 6728897
[TBL] [Abstract][Full Text] [Related]
3. Differential effect of cimetidine on drug oxidation (antipyrine and diazepam) vs. conjugation (acetaminophen and lorazepam): prevention of acetaminophen toxicity by cimetidine.
Abernethy DR; Greenblatt DJ; Divoll M; Ameer B; Shader RI
J Pharmacol Exp Ther; 1983 Mar; 224(3):508-13. PubMed ID: 6827475
[TBL] [Abstract][Full Text] [Related]
4. Influence of oral contraceptive use and cigarette smoking, alone and together, on antipyrine pharmacokinetics.
Scavone JM; Greenblatt DJ; Abernethy DR; Luna BG; Harmatz JS; Shader RI
J Clin Pharmacol; 1997 May; 37(5):437-41. PubMed ID: 9156376
[TBL] [Abstract][Full Text] [Related]
5. Antipyrine clearance and metabolism in patients with psoriasis.
Kubota K; Ishizaki T; Chiba K; Takagi A; Nakagawa A; Nakamura K
Br J Clin Pharmacol; 1986 Oct; 22(4):455-62. PubMed ID: 3768257
[TBL] [Abstract][Full Text] [Related]
6. Lack of effect of influenza vaccine on the pharmacokinetics of antipyrine, alprazolam, paracetamol (acetaminophen) and lorazepam.
Scavone JM; Blyden GT; Greenblatt DJ
Clin Pharmacokinet; 1989 Mar; 16(3):180-5. PubMed ID: 2721087
[TBL] [Abstract][Full Text] [Related]
7. Differential effects of enzyme induction on antipyrine metabolite formation.
Danhof M; Verbeek RM; van Boxtel CJ; Boeijinga JK; Breimer DD
Br J Clin Pharmacol; 1982 Mar; 13(3):379-86. PubMed ID: 7059438
[TBL] [Abstract][Full Text] [Related]
8. Antipyrine clearance and metabolite formation: the influence of liver volume and smoking.
Spoelstra P; Teunissen MW; Janssens AR; Weeda B; van Duijn W; Koch CW; Breimer DD
Eur J Clin Invest; 1986 Aug; 16(4):321-7. PubMed ID: 3093244
[TBL] [Abstract][Full Text] [Related]
9. Influence of the genetically controlled deficiency in debrisoquine hydroxylation on antipyrine metabolite formation.
Danhof M; Idle JR; Teunissen MW; Sloan TP; Breimer DD; Smith RL
Pharmacology; 1981; 22(6):349-58. PubMed ID: 7267701
[TBL] [Abstract][Full Text] [Related]
10. The disposition of antipyrine and its metabolites in young and elderly healthy volunteers.
Posner J; Danhof M; Teunissen MW; Breimer DD; Whiteman PD
Br J Clin Pharmacol; 1987 Jul; 24(1):51-5. PubMed ID: 3620285
[TBL] [Abstract][Full Text] [Related]
11. Enhanced antipyrine metabolism in cigarette smokers in Indian population.
Uppal R; Garg SK; Sharma PR; Nair CR; Chaudhury RR
Int J Clin Pharmacol Ther Toxicol; 1980 Jun; 18(6):269-71. PubMed ID: 7450928
[TBL] [Abstract][Full Text] [Related]
12. Effect of antipyrine coadministration on the kinetics of acetaminophen and lidocaine.
Blyden GT; Greenblatt DJ; LeDuc BW; Scavone JM
Eur J Clin Pharmacol; 1988; 35(4):413-7. PubMed ID: 3197750
[TBL] [Abstract][Full Text] [Related]
13. Effect of ciprofloxacin on antipyrine pharmacokinetics and metabolism in rats.
Anadón A; Martinez-Larrañaga MR; Fernandez MC; Diaz MJ; Bringas P
Antimicrob Agents Chemother; 1990 Nov; 34(11):2148-51. PubMed ID: 2073104
[TBL] [Abstract][Full Text] [Related]
14. Effects of parenteral amino acid nutritional regimens on oxidative and conjugative drug metabolism.
Pantuck EJ; Weissman C; Pantuck CB; Lee YJ
Anesth Analg; 1989 Dec; 69(6):727-31. PubMed ID: 2511781
[TBL] [Abstract][Full Text] [Related]
15. Substrate-selective inhibition by verapamil and diltiazem: differential disposition of antipyrine and theophylline in humans.
Abernethy DR; Egan JM; Dickinson TH; Carrum G
J Pharmacol Exp Ther; 1988 Mar; 244(3):994-9. PubMed ID: 3252045
[TBL] [Abstract][Full Text] [Related]
16. Influence of mild thyroid dysfunction on antipyrine clearance and metabolite formation in man.
Teunissen MW; van der Veen EA; Doodeman PJ; Breimer DD
Eur J Clin Pharmacol; 1984; 27(1):99-103. PubMed ID: 6489432
[TBL] [Abstract][Full Text] [Related]
17. Effect of aging and cigarette smoking on antipyrine and indocyanine green elimination.
Wood AJ; Vestal RE; Wilkinson GR; Branch RA; Shand DG
Clin Pharmacol Ther; 1979 Jul; 26(1):16-20. PubMed ID: 445957
[TBL] [Abstract][Full Text] [Related]
18. Physical exercise and improvement of liver oxidative metabolism in the elderly.
Mauriz JL; Tabernero B; García-López J; Jorquera F; Villa JG; González-Gallego J
Eur J Appl Physiol; 2000 Jan; 81(1-2):62-6. PubMed ID: 10552268
[TBL] [Abstract][Full Text] [Related]
19. Sources of interindividual variations in acetaminophen and antipyrine metabolism.
Nash RM; Stein L; Penno MB; Passananti GT; Vesell ES
Clin Pharmacol Ther; 1984 Oct; 36(4):417-30. PubMed ID: 6541104
[TBL] [Abstract][Full Text] [Related]
20. Effects of nifedipine on hepatic drug oxidation.
Dickinson TH; Egan JM; Abernethy DR
Pharmacology; 1988; 36(6):405-10. PubMed ID: 3420161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
